Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

US Patent 11186873 · Granted Nov 30, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →